Cancer stem cells and cell cycle regulation

Aaron N. Hata

Aaron N. Hata is an American cancer biologist and medical oncologist at Massachusetts General Hospital and Harvard Medical School who studies how tumor cells survive targeted therapy.

Andrea Alimonti (born 1975, Mendrisio, Switzerland) is an oncologist who directs the Institute of Oncology Research in Bellinzona, known for discovering PTEN-loss-induced cellular senescence in cancer.

Benjamin Deneen

Benjamin Deneen is a neuroscientist and professor at Baylor College of Medicine in Houston who studies glial biology and cancer neuroscience, known for work on astrocytes, glioma, and ependymoma.

Carla F. Kim

Carla F. Kim is an American stem cell biologist who studies lung stem cells and lung cancer, leading a laboratory at Boston Children's Hospital and teaching at Harvard Medical School.

Catriona Jamieson

Catriona H.M. Jamieson is a Canadian-American physician-scientist at UC San Diego who studies cancer stem cells, directs the Sanford Stem Cell Institute, and developed the ADAR1 inhibitor rebecsinib.

Cedric Blanpain

Cédric Blanpain, born 1970 in Belgium, is a physician-scientist and full professor at the Université Libre de Bruxelles known for identifying cancer stem cells in skin and breast cancers.

Charles J. Sherr

Charles J. Sherr is an American physician-scientist and emeritus researcher at St. Jude Children's Research Hospital known for discoveries in oncogenes, tumor suppressors, and cell cycle control.

Christian Buske

Christian Buske is a German hematologist and oncologist who leads the Institute of Experimental Tumor Research at University Hospital Ulm and studies leukemic stem cells in acute myeloid leukemia.

Christopher Heeschen

Christopher Heeschen is a German physician-scientist known for the first identification of pancreatic cancer stem cells, now a professor at Shanghai Jiao Tong University School of Medicine and director of a pancreatic cancer laboratory in Italy.

Clemens A. Schmitt

Clemens A. Schmitt, born 1967 in Frankfurt, is a German hematologist, oncologist, and cancer researcher who has led the University Clinic for Hematology and Internal Oncology at Kepler University Hospital in Linz since 2019.

Daniel G. Tenen

Daniel G. Tenen is a hematologist-oncologist and cancer researcher, Professor of Medicine at Harvard Medical School in Boston, known for work on PU.1, C/EBPα, and SALL4 in leukemia.

David M. Virshup

David M. Virshup is an American physician-scientist and cancer biologist known for research on Wnt signaling, and a professor at Duke University School of Medicine.

David Pellman

David Pellman is an American cell biologist and cancer geneticist at Dana-Farber Cancer Institute, known for explaining how cell division errors generate the chromosome abnormalities that drive cancer.

Dean G. Tang

Dean G. Tang is a cancer researcher who studies cancer cell heterogeneity and prostate cancer stem cells, chairing Pharmacology & Therapeutics at Roswell Park in Buffalo, New York.

Douglas J. Winton

Douglas J. Winton is a British cancer biologist at the University of Cambridge who studies intestinal stem cells and the earliest steps of bowel cancer.

Fernando Camargo

Fernando D. Camargo is a stem cell biologist and professor at Harvard University and Boston Children's Hospital, known for Hippo pathway and blood stem cell research.

Geoffrey I. Shapiro

Geoffrey I. Shapiro is a physician-scientist in medical oncology at Dana-Farber Cancer Institute in Boston and a Harvard Medical School professor who leads early-phase anticancer drug trials.

Gordon Peters

Gordon Peters (1948–2016) was a British molecular biologist at the Imperial Cancer Research Fund and Cancer Research UK, known for identifying the int-2 locus and the INK4a/ARF tumor suppressor locus.

Gustavo Leone

Gustavo Leone is an American cancer biologist known for work on Rb/E2F and PTEN signaling and cell cycle control, and director of the MCW Cancer Center since 2020.

Janis L. Abkowitz

Janis L. Abkowitz is an American hematologist at the University of Washington known for research on marrow-failure syndromes and elected to the National Academy of Medicine in 2013.

Jeanmarie Houghton

Jeanmarie Houghton is an American physician-scientist and Professor of Medicine at UMass Chan Medical School, best known for her 2004 Science paper reporting gastric cancer originating from bone marrow-derived cells.

Jeffrey Settleman

Jeffrey Settleman is an American cancer biologist who serves as Chief Scientific Officer for Oncology R&D at Pfizer, after 18 years as a Harvard Medical School professor.

Jeremy N. Rich

Jeremy N. Rich is an American neuro-oncologist and cancer stem cell researcher known for his work on glioblastoma stem cells. In 2025 he became deputy director for research and chief scientific officer of UNC Lineberger.

Oct 10, 2026

John Dick (cancer researcher)

John Dick is a Canadian cancer researcher at the Princess Margaret Cancer Centre in Toronto who showed in 1994 that leukemia is sustained by rare self-renewing stem cells.

John E. Dick

John E. Dick is a Canadian cancer stem cell biologist at the Princess Margaret Cancer Centre in Toronto who first identified leukemia stem cells in acute myeloid leukemia.

Joyce M. Slingerland

Joyce M. Slingerland, also known as Joyce Slingerland, is a Canadian-trained physician-scientist credited with discovering the cell-cycle inhibitor p27, and has been Professor of Oncology at Georgetown University since 2020.

Jürgen Knoblich

Jürgen Knoblich (born 1963) is a German developmental biologist at IMBA in Vienna whose laboratory introduced cerebral organoids, human stem-cell models of brain development, in 2013.

Keiichi I. Nakayama

Keiichi I. Nakayama (中山敬一) is a Japanese cancer biologist at Kyushu University and Institute of Science Tokyo known for p27 knockout mice and ubiquitin ligases.

Khandan Keyomarsi

Khandan Keyomarsi is a cancer biologist and professor of experimental radiation oncology at MD Anderson Cancer Center, known for linking low-molecular-weight cyclin E to breast cancer prognosis.